Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 547-553

  Kim, Mi Ra ^a   Choi, Hong Seok ^a   Heo, Tae Hwe ^b   Hwang, Sun Wook ^c   Kang, Keon Wook ^a  

^a Chosun University   (South Korea)

^b Konyang University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

AP 1; HIF 1 ; Pin1; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; OLIGODEOXYNUCLEOTIDE; PEPTIDYLPROLYL ISOMERASE PIN1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA RESPONSE ELEMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REPORTER GENE; TRANSCRIPTION INITIATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PEPTIDYLPROLYL ISOMERASE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 40849126563     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.045     Document Type: Article

References (36)

1. Lu K.P., Hanes S.D., and Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380 (1996) 544-547
2. Bayer E., Goettsch S., Mueller JW., Griewel B., Guiberman E., Mayr L.M., and Bayer P. Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J. Biol. Chem. 278 (2003) 26183-26193
3. Lu K.P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29 (2004) 200-209
4. Weiwad M., Kullertz G., Schutkowski M., and Fischer G. Evidence that the substrate backbone conformation is critical to phosphorylation by p42 MAP kinase. FEBS Lett. 478 (2000) 39-42
5. Zhou X.Z., Kops O., Werner A., et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6 (2000) 873-883
6. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., and Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20 (2001) 3459-3472
7. Bao L., Sauter G., Sowadski J., Lu K.P., and Wang D. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164 (2004) 1727-1737
8. Ayala G., Wang D., Wulf G., Frolov A., Li R., Sowadski J., Wheeler T.M., Lu K.P., and Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 63 (2003) 6244-6251
9. He J., Zhou F., Shao K., Hang J., Wang H., Rayburn E., Xiao Z.X., Lee S.W., Xue Q., Feng X.L., Shi S.S., Zhang C.Y., and Zhang S. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer 56 (2007) 51-58
10. Semenza G.L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35 (2000) 71-103
11. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000) 389-395
12. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
13. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
14. Ryo A., Uemura H., Ishiguro H., Saitoh T., Yamaguchi A., Perrem K., Kubota Y., Lu K.P., and Aoki I. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 15 (2005) 7523-7531
15. Yang J.W., Lee E.Y., and Kang K.W. ErbB2 overexpression in p53-inactivated mammary epithelial cells. FEBS Lett. 580 (2006) 6501-6508
16. Kang K.W., Wagley Y., Kim H.W., Pokharel Y.R., Chung Y.Y., Chang I.Y., Kim J.J., Moon J.S., Kim Y.K., Nah S.Y., Kang H.S., and Oh J.W. Novel role of IL-6/SIL-6R signaling in the expression of inducible nitric oxide synthase (iNOS) in murine B16, metastatic melanoma clone F10.9, cells. Free Radic. Biol. Med. 42 (2007) 215-227
17. Monje P., Hernandez-Losa J., Lyons R.J., Castellone M.D., and Gutkind J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280 (2005) 35081-35084
18. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., Xiong Q., Wang B., Li X.C., and Xie K. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61 (2001) 4143-4154
19. Li Y.Q., Tao K.S., Ren N., and Wang Y.H. Effect of c-fos antisense probe on prostaglandin E2-induced upregulation of vascular endothelial growth factor mRNA in human liver cancer cells. World J. Gastroenterol. 11 (2005) 4427-4430
20. Textor B., Sator-Schmitt M., Richter K.H., Angel P., and Schorpp-Kistner M. c-Jun and JunB are essential for hypoglycemia-mediated VEGF induction. Ann. N.Y. Acad. Sci. 1091 (2006) 310-318
21. Blancher C., Moore J.W., Talks K.L., Houlbrook S., and Harris A.L. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res. 60 (2000) 7106-7113
22. Chavez J.C., Baranova O., Lin J., and Pichiule P. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J. Neurosci. 26 (2006) 9471-9481
23. Lu K.P., Suizu F., Zhou X.Z., Finn G., Lam P., and Wulf G. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?. Mol. Carcinog. 45 (2006) 397-402
24. Brown J.M., and Giaccia A.J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58 (1998) 1408-1416
25. Kerbel R.S. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21 (2000) 505-515
26. Mercurio A.M., Bachelder R.E., Bates R.C., and Chung J. Semin. Cancer Biol. 14 (2004) 115-122
27. Rak J., Filmus J., Finkenzeller G., Grugel S., Marme D., and Kerbel R.S. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14 (1995) 263-277
28. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
29. Levy A.P., Levy N.S., and Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271 (1996) 2746-2753
30. Xie K., Wei D., Shi Q., and Huang S. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev. 15 (2004) 297-324
31. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8 (2002) S62-S67
32. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004) 1-12
33. Flügel D., Görlach A., Michiels C., and Kietzmann T. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol. Cell. Biol. 27 (2007) 3253-3265
34. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., and Abraham J.A. The human gene for vascular endothelial growth factor. J. Biol. Chem. 266 (1991) 11947-11954
35. Chabannes E., Fauconnet S., Bernardini S., Wallerand H., Adessi G., and Bittard H. Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells. Cell. Signal. 13 (2001) 585-591
36. Salnikow K., Kluz T., Costa M., Piquemal D., Demidenko Z.N., Xie K., and Blagosklonny M.V. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol. Cell. Biol. 22 (2002) 1734-1741